Amgen Announces Rhode Island Will Be Location of First US Next-Generation Biomanufacturing Plant

SourceDrug Discovery and Development Magazine
Date Published04/10/2018
Author NameAmgen
Mentions specific company case(s) of reshoring, kept from offshoring, or transplantYes

Additional Reshoring Information:

Company/Division name Amgen Rhode Island
Parent companyAmgen Inc
Type of work Manufacturing
Reshoring category:Reshoring
Total number of jobs (added or to be added):150
Year reshoring announced:2018
City reshored to:West Greenich
State(s) reshored to:RI
If relevant, work nearshored to:-
Product(s) reshoredbiomanufacturing
What domestic positive factors made reshoring more attractive?Automation/technology, Eco-system synergies, Government Incentives, Infrastructure, Image/brand, Impact on domestic economy, Manufacturing/engineering joint innovation (R&D), Skilled workforce availability/training, Under-utilized capacity
Find Reshoring Articles